Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
MRMaravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ Global Select · Currency in USD
$7.32 ▲ +0.25 (+3.54%)
At close: Oct 23, 4:00 PM ET. Market closed.
$7.32 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$7.07
Open
$7.06
Day's Range
$6.98 – $7.33
52 Week Range
$2.55 – $9.42
Volume
1,447,715
Avg. Volume
3,224,615
Market Cap
$2.08B
Beta (5Y Monthly)
0.61
PE Ratio (TTM)
--
EPS (TTM)
-$0.52
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$7.00

Profile: Maravai LifeSciences Holdings, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
415
CEO
Bernd Brust

Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate -$0.06 · Revenue est. $43.56M
DateEst.Actual
Aug 6, 2026-$0.04-$0.02Beat
May 7, 2026-$0.05$0.01Beat
Feb 25, 2026-$0.07-$0.04Beat
Nov 6, 2025-$0.06-$0.08Miss
Aug 11, 2025-$0.06-$0.08Miss
May 12, 2025-$0.07-$0.08Miss

Analyst view

Consensus price target
$7.00 ▼ -4.4%
Range $6.00 – $8.00
Rating: Buy
Buy 50% · Hold 43% · Sell 7%

Get free alerts on MRVI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.